Haemoglobin targets: we were wrong, time to move on

被引：72

作者：

Strippoli, Giovanni F. M. ^{[1
]}

Tognoni, Giovanni

机构：

[1] Univ Sydney, Sch Publ Hlth, Cochrane Renal Grp, Sydney, NSW 2006, Australia

[2] Univ Sydney, Sch Publ Hlth, Ctr Kidney Res, Sydney, NSW 2006, Australia

[3] Univ Sydney, Sch Publ Hlth, NHMRC Ctr Clin Res Excellence Renal Med, Sydney, NSW 2006, Australia

[4] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, I-66030 Santa Maria Imbaro, Italy

[5] Univ Rochester, Div Nephrol, Rochester, NY USA

来源：

LANCET | 2007年 / 369卷 / 9559期

关键词：

D O I：

10.1016/S0140-6736(07)60165-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：346 / 350

页数：5

共 18 条

[1]

[Anonymous], 2004, LANCET ONCOL, V5, P1

[2]

Armstrong D., The Wall Street Journal

[3] The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin [J].

Besarab, A ;

Bolton, WK ;

Browne, JK ;

Egrie, JC ;

Nissenson, AR ;

Okamoto, DM ;

Schwab, SJ ;

Goodkin, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :584-590

[4] Normalization of hemoglobin level in patients with chronic kidney disease and anemia [J].

Drueke, Tilman B. ;

Locatelli, Francesco ;

Clyne, Naomi ;

Eckardt, Kai-Uwe ;

Macdougall, Iain C. ;

Tsakiris, Dimitrios ;

Burger, Hans-Ulrich ;

Scherhag, Armin .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20) :2071-2084

[5]

Ioannidis JPA, 1998, AM J EPIDEMIOL, V148, P1117

[6] Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS) [J].

Locatelli, F ;

Pisoni, RL ;

Combe, C ;

Bommer, J ;

Andreucci, VE ;

Piera, L ;

Greenwood, R ;

Feldman, HI ;

Port, FK ;

Held, PJ .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (01) :121-132

[7] Anemia and cardiovascular risk: The lesson of the CREATE trial [J].

Locatelli, Francesco ;

Del Vecchio, Lucia ;

Pozzoni, Pietro .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 :S262-S266

[8] Rationale - Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease [J].

Mix, TCH ;

Brenner, RM ;

Cooper, ME ;

de Zeeuw, D ;

Ivanovich, P ;

Levey, AS ;

McGill, JB ;

McMurray, JJV ;

Parfrey, PS ;

Parving, HH ;

Pereira, BJG ;

Remuzzi, G ;

Singh, AK ;

Solomon, SD ;

Stehman-Breen, C ;

Toto, RD ;

Pfeffer, MA .

AMERICAN HEART JOURNAL, 2005, 149 (03) :408-413

[9] Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis [J].

Phrommintikul, Arintaya ;

Haas, Steven Joseph ;

Elsik, Maros ;

Krum, Henry .

LANCET, 2007, 369 (9559) :381-388

[10] Correction of anemia - Payoffs and problems [J].

Remuzzi, Giuseppe ;

Ingelfinger, Julie R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20) :2144-2146

← 1 2 →